New Study Indicates Significant Improvement In Progression-Free Survival For Patients With Advanced Pancreatic Neuroendocrine Tumors

Groundbreaking studies will be presented at the ESMO 12th World Congress on Gastrointestinal Cancer next week in Barcelona, Spain, including exciting new data on treatment for neuroendocrine tumors. Source: General Cancer News Articles Provided by Cancer Compass